For research use only. Not for therapeutic Use.
Ioxilan（Cat No.:R012689）is a nonionic, low-osmolar contrast agent used primarily in medical imaging, particularly in radiographic procedures like CT scans. It contains iodine, which enhances the visibility of blood vessels, organs, and tissues by absorbing X-rays, providing clear and detailed images for diagnostic purposes. Ioxilan is well-regarded for its safety profile, causing fewer adverse reactions compared to high-osmolar contrast agents. Its use is crucial in the accurate diagnosis and monitoring of various medical conditions, including cardiovascular diseases and tumors, enabling precise and effective patient care.
| Catalog Number | R012689 |
| CAS Number | 107793-72-6 |
| Synonyms | 5-[acetyl(2,3-dihydroxypropyl)amino]-3-N-(2,3-dihydroxypropyl)-1-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
| Molecular Formula | C18H24I3N3O8 |
| Purity | ≥95% |
| IUPAC Name | 5-[acetyl(2,3-dihydroxypropyl)amino]-3-N-(2,3-dihydroxypropyl)-1-N-(2-hydroxyethyl)-2,4,6-triiodobenzene-1,3-dicarboxamide |
| InChI | InChI=1S/C18H24I3N3O8/c1-8(28)24(5-10(30)7-27)16-14(20)11(17(31)22-2-3-25)13(19)12(15(16)21)18(32)23-4-9(29)6-26/h9-10,25-27,29-30H,2-7H2,1H3,(H,22,31)(H,23,32) |
| InChIKey | UUMLTINZBQPNGF-UHFFFAOYSA-N |
| SMILES | CC(=O)N(CC(CO)O)C1=C(C(=C(C(=C1I)C(=O)NCC(CO)O)I)C(=O)NCCO)I |
| Reference | [1]. Cheng KT. Ioxilan carbonate particles. National Center for Biotechnology Information (US); 2004-2013. 2007 Sep 1. [2]. Chow SL, et al. Effect of iodixanol and ioxilan on QT interval and renal function in patients with systolic heart failure. Int J Cardiol. 2012 Jan 12;154(1):17-21. [3]. Nonionic Contrast Agents. |
